Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable…
-Reported positive 16-week results from the extension phase of the Phase 2b RewinD-LB trial of neflamapimod in dementia with Lewy…
The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award!JACKSON CENTER, Pa., March 17, 2025 (GLOBE NEWSWIRE) --…
How Probiotics Are Transforming Dental Health and Redefining Oral HygieneTALLMADGE, Ohio, March 15, 2025 (GLOBE NEWSWIRE) -- In 2025, the…
SANTA ANA, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage…
New findings published in Alzheimer's & Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's,…
GENEVA, March 12, 2025 /PRNewswire/ -- In a historic move to combat the global crisis of violence against children, ISO has…
Rigorously tested, research-backed LTH protein powders, electrolytes, fish oil and more now available CHANHASSEN, Minn., March 12, 2025 /PRNewswire/ -- Life…
Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignanciesVANCOUVER, British Columbia, March…
Alzheimer’s disease (AD), affecting around 6.9 million people in the US, is ranked as the seventh leading cause of death…
